REGENXBIO Inc.

RGNXNASDAQ • USD
ThemeGenomics & Precision Med.›Gene Therapy & Gene Editing
6.08 USD
↘ 0.80 (11.63%)AT CLOSE (11:59 AM EDT)
6.50
↗ 0.42 (6.89%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
6.50
↗ 0.42 (6.89%)
🔴Market: CLOSED
Open?$6.83
High?$6.91
Low?$6.00
Prev. Close?$6.88
Volume?1.7M
Avg. Volume?1.7M
VWAP?$6.25
Rel. Volume?0.98x
Bid / Ask
Bid?$6.04 × 100
Ask?$6.50 × 1.0K
Spread?$0.46
Midpoint?$6.27
Valuation & Ratios
Market Cap?314.3M
Shares Out?51.7M
Float?38.7M
Float %?74.9%
P/E Ratio?N/A
P/B Ratio?14.91
EPS?-$5.61
Dividend?0.00%
Ex-Dividend?N/A

RGNX is currently priced at $6.08. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Strong Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, RGNX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
Themes
Healthcare - Genomics & Precision Medicine›Gene Therapy & Gene EditingBiotech - Drug Development›Rare Disease Therapeutics
Employees
371
Market Cap
314.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.regenxbio.com
Listed
2015-09-17
Address
9804 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
Phone: 240-552-8181
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
5
Short Sent.?
26
Piotroski F-Score?2/9Weak
Altman Z-Score?-6.21Distress
Confidence?71%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?18.46%High
Short Interest?7.1M
Days to Cover?3.2
Free Float38.7M
Avg Daily Volume2.2M
Settlement Date2026-05-15
Financial Health
Current Ratio?2.62Strong
Quick Ratio?2.62Strong
Cash Ratio?0.21Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
12
14.91HIGH▾
P/S?
Peers
100
S&P
43
3.58FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.2CHEAP▾
EV/Sales?
Peers
100
S&P
55
3.41FAIR▾
Returns & Efficiency
ROE?
S&P
3
-1,375.6%WEAK▾
ROA?
S&P
3
-84.8%WEAK▾
Cash Flow & Enterprise
FCF?$-236403000
Enterprise Value?$299.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist